Nicole Gifford

ID: 1b83c151-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

FDA Unexpectedly Rejects Pfizer’s Application for an Epoetin Alfa Biosimilar (Again)

Biosimilars Law Bulletin · June 28, 2017

Samsung Bioepis’ Imraldi® (adalimumab) Recommended for Approval in Europe

Biosimilars Law Bulletin · June 26, 2017

Fujifilm Kyowa Kirin Biologics Announces Application for Humira® (Adalimumab) Biosimilar Accepted by EMA

Biosimilars Law Bulletin · June 8, 2017

FDA Advisory Committee Meeting Announced for Amgen’s and Allergan’s Proposed Biosimilar to Avastin® (Bevacizumab)

Biosimilars Law Bulletin · June 8, 2017

Pfizer Challenges Genentech’s Carter ’213 Antibody Patent With Two New IPR Petitions

Biosimilars Law Bulletin · June 2, 2017

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.